In this four-part series, we will explore the various challenges facing orphan medicines entering the European market and suggest solutions that can help improve patient access. In the final part...
Read More
Challenges for orphan medicines entering the European market – Part 3: Economic evidence development
In this four-part series, we will explore the various challenges facing orphan medicines entering the European market and offer solutions that can help improve patient access. In Part 3 of...
Read More
Challenges for orphan medicines entering the European market – Part 2: Clinical evidence development
In this four-part series, we will explore the various challenges facing orphan medicines entering the European market and offer solutions that can help improve patient access. In Part 2 of...
Read More
In this four-part series, we will explore the various challenges facing orphan medicines entering the European market and offer solutions to help improve patient access. In Part 1, we will...
Read More
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
We’re delighted to announce that we will be exhibiting at ISPOR Europe in Barcelona over the 18th–20th November 2024. Mtech Access experts will be joined by our colleagues from across Petauri, including...
Read More
What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...
Read More
Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of ‘willingness to pay’ (WTP). Read on to explore 4 factors that impact WTP and compare 5 methodologies for price testing with payers.
Louise Maddison (Senior Consultant – Global Market Access, Mtech Access) explores the evolving market access landscape for AI-enabled Medtech, with a particular focus on the key European markets of France, Germany and the UK.
Louise Maddison joined Mtech Access as a Senior Consultant in our Market Access Team, earlier this year. Here, she talks about her career journey and her experiences since joining Mtech Access.
